Experience has shown that only 1/3 of all patients having a certain disease will recover if given the standard treatment. A new drug is to be tested on a group of twelve volunteers. If the FDA requires that at least seven of these patients recover before it will license the new drug, what is the probability that the treatment will be discredited even if it has the potential to increase an individual’s recovery rate to 1 / 2?